Hunter Associates Investment Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Hunter Associates Investment Management’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-100,000	Closed	-$62K	–	209
2020 Q4	$62K	Hold	100,000	–	–	0.02%	194
2020 Q3	$53K	Hold	100,000	–	–	0.01%	182
2020 Q2	$69K	Hold	100,000	–	–	0.02%	175
2020 Q1	$75K	Hold	100,000	–	–	0.03%	148
2019 Q4	$151K	Buy	+100,000	New	+$150K	0.05%	167
2017 Q4	–	Sell	-50,000	Closed	-$457K	–	164
2017 Q3	$457K	Hold	50,000	–	–	0.18%	102
2017 Q2	$365K	Hold	50,000	–	–	0.15%	115
2017 Q1	$360K	Buy	+50,000	New	+$310K	0.15%	120

Hunter Associates Investment Management's NEOS Position: Q1 2021 in Review

Hunter Associates Investment Management sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 100,000 shares — an estimated $62K sold.

Hunter Associates Investment Management first reported a position in NEOS in Q1 2017 and held it in 8 quarters. The position peaked at $457K in Q3 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

Hunter Associates Investment Management reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
Hunter Associates Investment Management sold 100,000 Neos Therapeutics, Inc shares in Q1 2021, an estimated $62K.
Hunter Associates Investment Management first reported a position in Neos Therapeutics, Inc in Q1 2017 and held it in 8 quarters.
Hunter Associates Investment Management's Neos Therapeutics, Inc position peaked at $457K in Q3 2017.
0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on Hunter Associates Investment Management's 13F filing for Q1 2021, filed 10 May 2021.